LBO — THE NEUROMEDICAL CENTER
IRR: 16.1% | MOIC: 2.11x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.1%
IRR
2.11x
MOIC
$13.7M
Entry EV
$20.2M
Exit EV
$7.0M
Equity Invested
Sources & Uses
S&UTotal · $13.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $5.3M | 38.8% | |
| Sub Debt | $1.3M | 9.7% | |
| Equity | $7.0M | 51.5% | |
| Enterprise Value | $13.3M | 97.1% | |
| Transaction Fees | $0.4M | 2.9% | |
| Total Uses | $13.7M | 100.0% |
Interpretation
INTAt 2.11x MOIC and 16.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $1.9M |
| Exit Ev | $20.2M |
| Net Debt At Exit | $5.4M |
| Equity At Exit | $14.9M |
| Equity Invested | $7.0M |
| Total Value Created | $7.8M |
| Value From Growth | $6.3M |
| Value From Multiple | $0.7M |
| Value From Deleveraging | $1.3M |